FDA Adverse Event Malfunction Summary report: N

OPTIPAC-S 40 REFOBACIN PLUS BONE CEMENT

MDR report key: 5678079 · Received May 25, 2016

Report

Report Number
3006946279-2016-00090
Event Type
Malfunction
Date Received
May 25, 2016
Date of Event
April 28, 2016
Report Date
April 29, 2016
Manufacturer
BIOMET FRANCE S.A.R.L.
Product Code
MBB
PMA / PMN Number
PN/A
Removal / Correction Number
N/A
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
AU
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THIS USER FACILITY IS OUTSIDE OF THE UNITED STATES. THE NECESSARY MANUFACTURING HISTORY TO REVIEW WAS NOT PROVIDED. CURRENT INFORMATION IS INSUFFICIENT TO PERMIT A CONCLUSION AS TO THE CAUSE OF THE EVENT. THIS PRODUCT IS MANUFACTURED BY ZIMMER BIOMET (B)(4) AND IS NOT CLEARED OR DISTRIBUTED IN THE U.S. HOWEVER, THIS REPORT IS BEING SUBMITTED AS ZIMMER BIOMET IN (B)(4) MANUFACTURES A SIMILAR DEVICE IN THE UNITED STATES UNDER 510K NUMBER K150850. PRODUCT LOCATION UNKNOWN.

Description of Event or Problem · 1

DURING AN UNKNOWN PROCEDURE, THE CEMENT DID NOT HARDEN. THIS RESULTED IN AN UNKNOWN DELAY IN PROCEDURE. ANOTHER UNIT WAS AVAILABLE TO COMPLETE THE PROCEDURE WITHOUT PATIENT INJURY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
334633 OPTIPAC-S 40 REFOBACIN PLUS BONE CEMENT BONE CEMENT, ANTIBIOTIC MBB BIOMET FRANCE S.A.R.L. N/A A521B04770

Patients

Seq Age Sex Outcome Treatment
1